Work

Updated Results of a Phase I Study of RAD001 In Combination with Lenalidomide In Patients with Relapsed or Refractory Multiple Myeloma with Pharmacodynamic and Pharmacokinetic Analysis

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.3051.3051

Authors: Anuj Mahindra, Paul G Richardson, Parameswaran Hari, Aliyah R. Sohani, Jacob P. Laubach, Jill Burke, Sarah Kaster, Christine Connolly, Linda Rivera, Paulette Jacobs, Ayman Saad, Kathleen Colson, Irene Ghobrial, Robert L. Schlossman, Jennifer Adams, Wendy Makrides, Edie Weller, Nikhil C. Munshi, Kenneth C. Anderson, Noopur Raje

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Medical College of Wisconsin, Froedtert Hospital, Harvard University, Celgene (United States), VA Boston Healthcare System

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588435523

FWCI: 1.616

Cites:

Cited by: 10

Related to: 10